Logic | $4,300,000 | (Oct 21, 2025)
Lette AI | $1,400,000 | (Oct 21, 2025)
Avid | $6,500,000 | (Oct 21, 2025)
InBrain Pharma
France
- Loos, Hauts-de-France
- 13/05/2025
- Unknown
- $2,000,943
InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinsonâs Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the UniversitĂ©Ì de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised âŹ4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results have just been obtained.
- Industry Biotechnology Research
- Website https://www.inbrainpharma.com/
- LinkedIn https://www.linkedin.com/company/in-brain-pharma/
Related People
VĂ©ronique Foutel, DrFounder
France -
Lille, Hauts-de-France
Value Vision Consulting SAS is a healthcare consultancy offering a set of market access and pricing services towards pharmaceutical innovation promoters (Life Science Investors, Biotech, Pharma Industry). Our services are aimed at supporting day-to-day operations (such as pharmaceutical price & reimbursement strategy definition, P&R applications, negotiations, reevaluation) as well as strategic corporate exercises (drug licensing, M&A, fundraising).
Adaptyx Biosciences | $14,000,000 | (Oct 21, 2025)
Andel | $4,500,000 | (Oct 21, 2025)
Triplemoon | $3,500,000 | (Oct 21, 2025)
Magic(US) | $10,000,000 | (Oct 21, 2025)
CoMind | $60,000,000 | (Oct 21, 2025)
Armstrong Robotics | $12,000,000 | (Oct 21, 2025)
AdsGency AI | $12,000,000 | (Oct 21, 2025)
Chatfuel | $1,500,000 | (Oct 21, 2025)
Fourier Health | $8,400,000 | (Oct 21, 2025)